Cite

MLA Citation

    Christina Rautenberg et al.. “Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT.” European journal of haematology, vol. 98, n.d., pp. 348–354. http://access.bl.uk/ark:/81055/vdc_100044495960.0x000046
  
Back to record